The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
You must be logged in and own this session in order to
post comments.
Leo OzurumbaDwight
1/13/21 11:46 am
Good day sir.
This is now an emerging trend in search for Sarscov-2 Ab drugs- ensuring it's capacity for cross neutralization across emerging strains.
Then, not loosing sight of qualities for long lasting protection.
Testing mAb with support mAb in cocktails
version against Sarscov-2 is also emerging, to support efficacy, as reported from some studies.
Nice work sir.
Wrm regards.
Leo Ozurumba-Dwight
Leo OzurumbaDwight
1/13/21 11:46 am
Good day sir. This is now an emerging trend in search for Sarscov-2 Ab drugs- ensuring it's capacity for cross neutralization across emerging strains. Then, not loosing sight of qualities for long lasting protection. Testing mAb with support mAb in cocktails version against Sarscov-2 is also emerging, to support efficacy, as reported from some studies. Nice work sir. Wrm regards. Leo Ozurumba-Dwight